Wednesday, December 05, 2012

BIG PHARMA NAILED IN DOJ ANTI-FRAUD PROBE

This is part of my continuing pursuit of material for a manuscript I'm trying to develop about my 11-year experience so far with prostate cancer -- from the U.S. Department of Justice web site -- Other investigations also turned up fraud involving prostate cancer hormone treatment drugs Lupron and Zoladex ...

Huge billion dollar penalties levied under U.S. anti-fraud law enforced by the Department of Justice:

Quote from story:

"Enforcement actions involving the pharmaceutical and medical device industry were the source of some of the largest recoveries this year. The department recovered nearly $2 billion in cases alleging false claims for drugs and medical devices under federally insured health programs and, in addition, returned $745 million to state Medicaid programs. These cases include recoveries from GlaxoSmithKline LLC (GSK) and Merck, Sharp & Dohme (Merck) – two of the three top settlements this year. These recoveries do not include a $561 million False Claims Act settlement with Abbott Laboratories Inc., part of a $1.5 billion global resolution (which will be reflected in FY 2013 numbers)"


No comments: